<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192760</url>
  </required_header>
  <id_info>
    <org_study_id>UHZ Bad Krozingen-cathlab</org_study_id>
    <nct_id>NCT04192760</nct_id>
  </id_info>
  <brief_title>Culotte Versus DK-CRUSH Technique in Non-left Main Coronary Bifurcation Lesions</brief_title>
  <acronym>BBK-3</acronym>
  <official_title>Bifurcations Bad Krozingen (BBK) 3 - Trial Randomised Comparison of Culotte-stenting Versus DK-Crush--stenting for the Treatment of de Novo Non-left Main Coronary Bifurcation Lesions With Everolimus-eluting Stents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Heart Center Freiburg - Bad Krozingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Heart Center Freiburg - Bad Krozingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised comparison of Culotte technique versus &quot;Double Kissing&quot; - Crush technique&#xD;
      (DK-Crush) for the percutaneous treatment of de novo non-left main coronary bifurcation&#xD;
      lesions with modern everolimus-eluting stents (DES) - German multicenter study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of study This prospective randomized multicenter study will compare the long-term safety&#xD;
      and efficacy of Culotte stenting versus &quot;Double Kissing&quot; - Crush (DK-Crush) stenting in the&#xD;
      treatment of the de-novo non-left main coronary bifurcation lesions with new generation&#xD;
      everolimus-eluting stents.&#xD;
&#xD;
      Study hypothesis In large coronary bifurcation lesions (main vessel &gt; 2.5mm, side branch &gt;&#xD;
      2.25mm) including significant ostial side branch disease, Culotte stenting compared with&#xD;
      DKcrush stenting reduces maximal percent diameter stenosis at the bifurcation at 9-month&#xD;
      follow-up by 25 %.&#xD;
&#xD;
      Study design Prospective, randomized, German multicenter study.&#xD;
&#xD;
      Methods Four-hundred patients, in whom a double-stenting technique is intended for the&#xD;
      treatment of a non-left main de-novo coronary bifurcation lesion will be randomly assigned to&#xD;
      Culotte stenting or to DK-crush stenting with an approved drug-eluting stent (SYNERGY-Stent).&#xD;
      As a part of usual care, patients will undergo 9-month angiographic follow-up with&#xD;
      quantitative coronary angiography. Clinical follow-up is planned at 1 year if no angiographic&#xD;
      follow-up is obtained.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic restenosis in the bifurcation lesion by quantitative coronary analysis (QCA)</measure>
    <time_frame>9 months post index percutaneous coronary intervention (PCI)</time_frame>
    <description>For quantitative coronary angiography, changes between result at the completion of the index intervention and at 9 months follow-up will be analysed using a computer based system dedicated to bifurcation analysis, according to the standard operating procedure of the angiographic core laboratory.&#xD;
Quantitative angiographic measurements will be obtained of the three segments of the bifurcation lesion: the proximal and distal segment of the main branch and the side branch. We will perform measurements in the stented portion of the vessel (in-stent) and in the distal or proximal 5 mm margin (edge). In-segment analyses will comprise the in-stent and the edge area.&#xD;
In addition, the bifurcation angle from the analysis system will be estimated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of target lesion revascularisation (TLR)</measure>
    <time_frame>1 year</time_frame>
    <description>Any revascularisation (Re-PCI or CABG) at segments treated during index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major adverse cardiac events (MACE)</measure>
    <time_frame>1 year</time_frame>
    <description>MACE defined as death, Myocardial infarction (Q wave and Non-Q wave), emergent cardiac bypass surgery, or TLR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of binary restenosis at any segment of the bifurcation lesion</measure>
    <time_frame>9 months</time_frame>
    <description>≥ 50% diameter stenosis in the main and side branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of binary restenosis in the main and side branch</measure>
    <time_frame>9 months</time_frame>
    <description>≥ 50% diameter stenosis in main and side branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stent thrombosis (ST)</measure>
    <time_frame>1 year</time_frame>
    <description>Post-procedure thrombotic stent occlusion according to the Academic Research Consortium-criteria</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of device success</measure>
    <time_frame>9 months</time_frame>
    <description>Attainment of &lt; 30% residual stenosis of the target lesion in the main and side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean procedure time</measure>
    <time_frame>Index Intervention</time_frame>
    <description>Procedure time measured in minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean radiation exposure</measure>
    <time_frame>Index Intervention</time_frame>
    <description>Radiation exposure measured in cGym²</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean volume of used contrast medium</measure>
    <time_frame>Index Intervention</time_frame>
    <description>Contrast medium measured in milliliters</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Coronary Stenosis</condition>
  <condition>Stent Stenosis</condition>
  <arm_group>
    <arm_group_label>Culotte Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Both vessels have to be wired. Lesion preparation in the main vessel and side branch may be undertaken according to operator preference. After lesion preparation, the side branch has to be stented first. The first stent is placed from main branch into the side branch, covering the entire diseased segment with a wire jailed in the main vessel. The main vessel is rewired through the stent struts, and after removal of the jailed wire, is dilated with a balloon to separate stent struts. The side branch wire is then removed and the main vessel is stented covering the proximal and distal segment. The side-branch is re-wired and high pressure individual inflations are made in each vessel at the bifurcation point to ensure good stent strut separation. Afterwards, a lower pressure kissing inflation is made. Balloon sizing should be in accordance with the diameter of the vessel itself. Finally, a proximal optimization (POT) procedure is performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DK-Crush Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Both vessels have to be wired first. Lesion preparation in the main vessel and side branch may be undertaken according to operator preference (rotablation, if needed).&#xD;
After lesion preparation, the side branch is stented first. Side branch stent should have a small protrusion into the main branch. Before stent implantation in the side branch, an adequately sized balloon should be placed in the main branch, just opposite to the side branch ostium. After stent implantation in the side branch, stent balloon and wire are removed and the balloon in the main branch must be inflated, to crush the struts into the vessel wall. In next step, the new wire should be crossed into the ostium of the side branch and first kissing balloon dilatation will follow. The next step is to implant the second stent into the main branch, followed by second re-wiring, a second kissing balloon-dilatation and final proximal optimization (POT) procedure (single short balloon inflation in proximal segment).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stenting</intervention_name>
    <description>Comparison of two technical approaches in the interventional treatment on de-novo non-left main coronary lesions</description>
    <arm_group_label>Culotte Technique</arm_group_label>
    <arm_group_label>DK-Crush Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Clinical indication, evidenced by angina / angina-equivalent symptoms or documented&#xD;
             ischemia (non-invasive imaging such as scintigraphy, stress-MRI or stress-echo; FFR or&#xD;
             iwFR) or patients with acute coronary syndromes (NSTE-ACS).&#xD;
&#xD;
          2. Clinical indication to perform double stenting only with Synergy™ stents for a&#xD;
             clinically significant bifurcation stenosis as judged by the operator.&#xD;
&#xD;
          3. De-novo non-Ieft main coronary bifurcation lesions - 1,1,1 or 0,1,1 according to the&#xD;
             Medina classification - of a native coronary artery with the following reference&#xD;
             vessel diameters: main branch &gt; 2,5 mm; side branch &gt; 2,25 mm. The difference between&#xD;
             vessel diameter of the main and side branch is ≤ 1 mm.&#xD;
&#xD;
          4. The target lesion has not been previously treated with any interventional procedure.&#xD;
&#xD;
          5. The target vessel (main branch and side branch) must appear feasible for stent&#xD;
             implantation.&#xD;
&#xD;
          6. Patient has no other coronary intervention planned within 30 days of the procedure.&#xD;
&#xD;
          7. Patient has been informed of the nature of the study and agrees to its provisions and&#xD;
             has written informed consent as approved by the Ethics Committee.&#xD;
&#xD;
          8. Patient is willing to comply with all required post-procedure follow-up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient had an acute ST-elevation myocardial infarction within 72 h preceding the&#xD;
             index procedure or target vessel contains intraluminal thrombus.&#xD;
&#xD;
          2. Use of any other coronary stent than Synergy™ and Synergy Megatron™ except for&#xD;
             baiI-out situations.&#xD;
&#xD;
          3. Patient with a known hypersensitivity or contraindication to the needed antithrombotic&#xD;
             therapy, stent type or contrast media that cannot be adequately pre-medicated.&#xD;
&#xD;
          4. Non successful treatment of other lesion during the same procedure.&#xD;
&#xD;
          5. Patient with a severe bleeding diathesis, history of recent major bleeding or stroke&#xD;
             (≤ 6 months), coagulopathy or severe liver disease.&#xD;
&#xD;
          6. Patient has a co-morbidity (i.e. cancer) that may cause the patient to be noncompliant&#xD;
             with the protocol, or is associated with limited life-expectancy (Iess than 1 year).&#xD;
&#xD;
          7. Patient is participating in any other clinical study with an investigational product.&#xD;
&#xD;
          8. Patient is known to be pregnant or lactating at time of inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Miroslaw Ferenc, MD</last_name>
    <phone>0049 7633 4020</phone>
    <email>miroslaw.ferenc@uniklinik-freiburg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Heart Center Freiburg • Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <state>Suedring 15</state>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslaw Ferenc, PD Dr.</last_name>
      <phone>0049 7633 4020</phone>
      <email>Miroslaw.Ferenc@universitaets-herzzentrum.de</email>
    </contact>
    <contact_backup>
      <last_name>Franz-Josef Neumann, Prof. Dr.</last_name>
      <phone>0049 7633 4020</phone>
      <email>Franz-Josef.Neumann@universitaets-herzzentrum.de</email>
    </contact_backup>
    <investigator>
      <last_name>Miroslaw Ferenc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz-u. Diabeteszentrum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herz-und Gefäßzentrum</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Johannes-Hospital</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Dresden an der Technischen Universität</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Elisabeth Krankenhaus</name>
      <address>
        <city>Essen</city>
        <zip>45138</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg/UHZ</name>
      <address>
        <city>Freiburg</city>
        <zip>79110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum</name>
      <address>
        <city>München</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Trier</name>
      <address>
        <city>Trier</city>
        <zip>54292</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89070</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Ferenc M, Gick M, Comberg T, Rothe J, Valina C, Toma A, Löffelhardt N, Hochholzer W, Riede F, Kienzle RP, Achtari A, Neumann FJ. Culotte stenting vs. TAP stenting for treatment of de-novo coronary bifurcation lesions with the need for side-branch stenting: the Bifurcations Bad Krozingen (BBK) II angiographic trial. Eur Heart J. 2016 Dec 1;37(45):3399-3405. doi: 10.1093/eurheartj/ehw345. Epub 2016 Aug 30.</citation>
    <PMID>27578807</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, Kwan TW, Paiboon C, Zhou YJ, Lv SZ, Dangas GD, Xu YW, Wen SY, Hong L, Zhang RY, Wang HC, Jiang TM, Wang Y, Sansoto T, Chen F, Yuan ZY, Li WM, Leon MB. Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1335-1342. doi: 10.1016/j.jcin.2015.05.017.</citation>
    <PMID>26315736</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SL, Zhang JJ, Ye F, Chen YD, Lü SZ, Tan H, Patel T, Kenji K, Tamari I, Shan SJ, Zhu ZS, Lin S, Tian NL, Li XB, Liu ZZ, Lee M, Wei M, Xu YW, Yuan ZB, Qian J, Sun XW, Yang S, Chen JG, He B, Sumit S. [Comparison of DK crush with classical crush technique with drug-eluting stents for the treatment of coronary bifurcation lesions from DKCRUSH-1 study]. Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Feb;36(2):100-7. Chinese.</citation>
    <PMID>19099943</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SL, Santoso T, Zhang JJ, Ye F, Xu YW, Fu Q, Kan J, Paiboon C, Zhou Y, Ding SQ, Kwan TW. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial. J Am Coll Cardiol. 2011 Feb 22;57(8):914-20. doi: 10.1016/j.jacc.2010.10.023.</citation>
    <PMID>21329837</PMID>
  </results_reference>
  <results_reference>
    <citation>Erglis A, Kumsars I, Niemelä M, Kervinen K, Maeng M, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Mäkikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Syvänne M, Helqvist S, Kjell N, Wiseth R, Aarøe J, Puhakka M, Thuesen L; Nordic PCI Study Group. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study. Circ Cardiovasc Interv. 2009 Feb;2(1):27-34. doi: 10.1161/CIRCINTERVENTIONS.108.804658. Epub 2009 Feb 10.</citation>
    <PMID>20031690</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferenc M, Buettner HJ, Gick M, Comberg T, Rothe J, Khoury F, Valina C, Toma A, Kuebler P, Riede F, Neumann FJ. Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents. Clin Res Cardiol. 2016 Mar;105(3):230-8. doi: 10.1007/s00392-015-0911-7. Epub 2015 Sep 2.</citation>
    <PMID>26329585</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee JM, Hahn JY, Kang J, Park KW, Chun WJ, Rha SW, Yu CW, Jeong JO, Jeong MH, Yoon JH, Jang Y, Tahk SJ, Gwon HC, Koo BK, Kim HS. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1318-1331. doi: 10.1016/j.jcin.2015.05.014.</citation>
    <PMID>26315734</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 27, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Heart Center Freiburg - Bad Krozingen</investigator_affiliation>
    <investigator_full_name>Dr. Miroslaw FERENC</investigator_full_name>
    <investigator_title>Director of interventional cardiology department</investigator_title>
  </responsible_party>
  <keyword>PCI</keyword>
  <keyword>stent</keyword>
  <keyword>bifurcation</keyword>
  <keyword>Culotte</keyword>
  <keyword>DK-Crush</keyword>
  <keyword>restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT04192760/Prot_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT04192760/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

